JACKSON THORNTON WEALTH MANAGEMENT, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1903880 MONTGOMERY, AL

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$443,765

+$14,293 QoQ

Shares Held

2,633

-19.2% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#490

of 768 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JACKSON THORNTON WEALTH MANAGEMENT, LLC holds $997,353 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (44.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc This page	2,633	$443,765
2	TAK	Takeda Pharmaceutical Co Ltd	21,893	$350,944
3	UTHR	UNITED THERAPEUTICS Corp	374	$202,644

All Filings in NBIX

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$443,765	2,633	-19.2%	Shares	Sole	2026-08-06
2026-03-31	$429,472	3,260	-7.1%	Shares	Other	2026-04-29
2025-12-31	$497,539	3,508	+4.1%	Shares	Other	2026-01-22
2025-09-30	$473,220	3,371	—	Shares	Sole	2025-10-29
No filing history on record for this holder in this stock.